Skip to main content
Erschienen in: European Radiology 11/2019

23.04.2019 | Urogenital

Value of blood oxygenation level-dependent MRI for predicting clinical outcomes in uterine cervical cancer treated with concurrent chemoradiotherapy

verfasst von: Jiyeong Lee, Chan Kyo Kim, Kyo-won Gu, Won Park

Erschienen in: European Radiology | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To investigate the value of blood oxygenation level-dependent (BOLD) MRI as a predictor of clinical outcomes in cervical cancer patients treated with concurrent chemoradiotherapy (CCRT).

Method

Enrolled 92 patients with stage IB2–IVB cervical cancer who received CCRT underwent 3-T BOLD MRI before treatment. The R2* value (rate of spin dephasing, s−1) was measured in the tumor. Cox regression analysis was used to evaluate the associations of imaging and clinical parameters with progression-free survival (PFS) and cancer-specific survival (CSS). Inter-reader reliability for the R2* measurements was evaluated using an intraclass correlation coefficient (ICC).

Results

Tumor R2* values were significantly different between patients with and without disease progression (p < 0.001). Multivariate analysis demonstrated that tumor R2* value was significantly independent factor for PFS (hazard ratio [HR] = 5.746, p < 0.001) and CSS (HR = 12.878, p = 0.001). Additionally, squamous cell carcinoma antigen (HR = 1.027, p = 0.001) was significantly independent factor for PFS. Inter-reader reliability for the R2* measurements was good (ICC = 0.702).

Conclusion

Pretreatment 3-T BOLD MRI may be useful for predicting clinical outcomes in uterine cervical cancer patients treated with CCRT, with good inter-reader reliability.

Key Points

Tumor R2* values are different between patients with and without disease progression.
• The R2* value is an independent factor for treatment outcomes in cervical cancer.
• Inter-reader reliability for R2* measurements using BOLD MRI is good.
Literatur
1.
Zurück zum Zitat Datta NR, Stutz E, Liu M et al (2017) Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: a systematic review and meta-analysis. Gynecol Oncol 145:374–385CrossRef Datta NR, Stutz E, Liu M et al (2017) Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: a systematic review and meta-analysis. Gynecol Oncol 145:374–385CrossRef
2.
Zurück zum Zitat Rose PG, Bundy BN, Watkins EB et al (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144–1153CrossRef Rose PG, Bundy BN, Watkins EB et al (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144–1153CrossRef
3.
Zurück zum Zitat Fyles A, Milosevic M, Hedley D et al (2002) Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 20:680–687CrossRef Fyles A, Milosevic M, Hedley D et al (2002) Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 20:680–687CrossRef
4.
Zurück zum Zitat Bentzen L, Keiding S, Nordsmark M et al (2003) Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours. Radiother Oncol 67:339–344CrossRef Bentzen L, Keiding S, Nordsmark M et al (2003) Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours. Radiother Oncol 67:339–344CrossRef
5.
Zurück zum Zitat Mannelli L, Patterson AJ, Zahra M et al (2010) Evaluation of nonenhancing tumor fraction assessed by dynamic contrast-enhanced MRI subtraction as a predictor of decrease in tumor volume in response to chemoradiotherapy in advanced cervical cancer. AJR Am J Roentgenol 195:524–527CrossRef Mannelli L, Patterson AJ, Zahra M et al (2010) Evaluation of nonenhancing tumor fraction assessed by dynamic contrast-enhanced MRI subtraction as a predictor of decrease in tumor volume in response to chemoradiotherapy in advanced cervical cancer. AJR Am J Roentgenol 195:524–527CrossRef
6.
Zurück zum Zitat Mayr NA, Yuh WT, Zheng J et al (1998) Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging. AJR Am J Roentgenol 170:177–182CrossRef Mayr NA, Yuh WT, Zheng J et al (1998) Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging. AJR Am J Roentgenol 170:177–182CrossRef
7.
Zurück zum Zitat Zahra MA, Tan LT, Priest AN et al (2009) Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Int J Radiat Oncol Biol Phys 74:766–773CrossRef Zahra MA, Tan LT, Priest AN et al (2009) Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Int J Radiat Oncol Biol Phys 74:766–773CrossRef
8.
Zurück zum Zitat Gui B, Micco M, Valentini AL et al (2018) Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery-the “PRICE” study 2: role of conventional and DW-MRI. Eur Radiol Gui B, Micco M, Valentini AL et al (2018) Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery-the “PRICE” study 2: role of conventional and DW-MRI. Eur Radiol
9.
Zurück zum Zitat Thomeer MG, Vandecaveye V, Braun L et al (2019) Evaluation of T2-W MR imaging and diffusion-weighted imaging for the early post-treatment local response assessment of patients treated conservatively for cervical cancer: a multicentre study. Eur Radiol 29:309–318CrossRef Thomeer MG, Vandecaveye V, Braun L et al (2019) Evaluation of T2-W MR imaging and diffusion-weighted imaging for the early post-treatment local response assessment of patients treated conservatively for cervical cancer: a multicentre study. Eur Radiol 29:309–318CrossRef
10.
Zurück zum Zitat Yang W, Qiang JW, Tian HP, Chen B, Wang AJ, Zhao JG (2018) Multi-parametric MRI in cervical cancer: early prediction of response to concurrent chemoradiotherapy in combination with clinical prognostic factors. Eur Radiol 28:437–445CrossRef Yang W, Qiang JW, Tian HP, Chen B, Wang AJ, Zhao JG (2018) Multi-parametric MRI in cervical cancer: early prediction of response to concurrent chemoradiotherapy in combination with clinical prognostic factors. Eur Radiol 28:437–445CrossRef
11.
Zurück zum Zitat Wakefield JC, Downey K, Kyriazi S, deSouza NM (2013) New MR techniques in gynecologic cancer. AJR Am J Roentgenol 200:249–260CrossRef Wakefield JC, Downey K, Kyriazi S, deSouza NM (2013) New MR techniques in gynecologic cancer. AJR Am J Roentgenol 200:249–260CrossRef
12.
Zurück zum Zitat O’Connor JP, Naish JH, Parker GJ et al (2009) Preliminary study of oxygen-enhanced longitudinal relaxation in MRI: a potential novel biomarker of oxygenation changes in solid tumors. Int J Radiat Oncol Biol Phys 75:1209–1215CrossRef O’Connor JP, Naish JH, Parker GJ et al (2009) Preliminary study of oxygen-enhanced longitudinal relaxation in MRI: a potential novel biomarker of oxygenation changes in solid tumors. Int J Radiat Oncol Biol Phys 75:1209–1215CrossRef
13.
Zurück zum Zitat Kim CK, Park SY, Park BK, Park W, Huh SJ (2014) Blood oxygenation level-dependent MR imaging as a predictor of therapeutic response to concurrent chemoradiotherapy in cervical cancer: a preliminary experience. Eur Radiol 24:1514–1520CrossRef Kim CK, Park SY, Park BK, Park W, Huh SJ (2014) Blood oxygenation level-dependent MR imaging as a predictor of therapeutic response to concurrent chemoradiotherapy in cervical cancer: a preliminary experience. Eur Radiol 24:1514–1520CrossRef
14.
Zurück zum Zitat Hallac RR, Ding Y, Yuan Q et al (2012) Oxygenation in cervical cancer and normal uterine cervix assessed using blood oxygenation level-dependent (BOLD) MRI at 3T. NMR Biomed 25:1321–1330CrossRef Hallac RR, Ding Y, Yuan Q et al (2012) Oxygenation in cervical cancer and normal uterine cervix assessed using blood oxygenation level-dependent (BOLD) MRI at 3T. NMR Biomed 25:1321–1330CrossRef
15.
Zurück zum Zitat Choi SH, Kim CK, Park JJ, Park BK (2016) Assessment of early therapeutic changes to concurrent chemoradiotherapy in uterine cervical cancer using blood oxygenation level-dependent magnetic resonance imaging. J Comput Assist Tomogr 40:730–734CrossRef Choi SH, Kim CK, Park JJ, Park BK (2016) Assessment of early therapeutic changes to concurrent chemoradiotherapy in uterine cervical cancer using blood oxygenation level-dependent magnetic resonance imaging. J Comput Assist Tomogr 40:730–734CrossRef
16.
Zurück zum Zitat Sironi S, Buda A, Picchio M et al (2006) Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology 238:272–279CrossRef Sironi S, Buda A, Picchio M et al (2006) Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology 238:272–279CrossRef
17.
Zurück zum Zitat Budczies J, Klauschen F, Sinn BV et al (2012) Cutoff Finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization. PLoS One 7:e51862CrossRef Budczies J, Klauschen F, Sinn BV et al (2012) Cutoff Finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization. PLoS One 7:e51862CrossRef
18.
Zurück zum Zitat Adams GE, Hasan NM, Joiner MC (1997) The Klaas Breur Lecture. Radiation, hypoxia and genetic stimulation: implications for future therapies. Radiother Oncol 44:101–109CrossRef Adams GE, Hasan NM, Joiner MC (1997) The Klaas Breur Lecture. Radiation, hypoxia and genetic stimulation: implications for future therapies. Radiother Oncol 44:101–109CrossRef
19.
Zurück zum Zitat Brown JM, Giaccia AJ (1998) The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58:1408–1416PubMed Brown JM, Giaccia AJ (1998) The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58:1408–1416PubMed
20.
Zurück zum Zitat Lyng H, Sundfor K, Trope C, Rofstad EK (2000) Disease control of uterine cervical cancer: relationships to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy. Clin Cancer Res 6:1104–1112PubMed Lyng H, Sundfor K, Trope C, Rofstad EK (2000) Disease control of uterine cervical cancer: relationships to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy. Clin Cancer Res 6:1104–1112PubMed
21.
Zurück zum Zitat Lyng H, Malinen E (2017) Hypoxia in cervical cancer: from biology to imaging. Clin Transl Imaging 5:373–388CrossRef Lyng H, Malinen E (2017) Hypoxia in cervical cancer: from biology to imaging. Clin Transl Imaging 5:373–388CrossRef
22.
Zurück zum Zitat Pacheco-Torres J, Lopez-Larrubia P, Ballesteros P, Cerdan S (2011) Imaging tumor hypoxia by magnetic resonance methods. NMR Biomed 24:1–16CrossRef Pacheco-Torres J, Lopez-Larrubia P, Ballesteros P, Cerdan S (2011) Imaging tumor hypoxia by magnetic resonance methods. NMR Biomed 24:1–16CrossRef
23.
Zurück zum Zitat Price JM, Robinson SP, Koh DM (2013) Imaging hypoxia in tumours with advanced MRI. Q J Nucl Med Mol Imaging 57:257–270PubMed Price JM, Robinson SP, Koh DM (2013) Imaging hypoxia in tumours with advanced MRI. Q J Nucl Med Mol Imaging 57:257–270PubMed
24.
Zurück zum Zitat Li SP, Padhani AR, Makris A (2011) Dynamic contrast-enhanced magnetic resonance imaging and blood oxygenation level-dependent magnetic resonance imaging for the assessment of changes in tumor biology with treatment. J Natl Cancer Inst Monogr 2011:103–107CrossRef Li SP, Padhani AR, Makris A (2011) Dynamic contrast-enhanced magnetic resonance imaging and blood oxygenation level-dependent magnetic resonance imaging for the assessment of changes in tumor biology with treatment. J Natl Cancer Inst Monogr 2011:103–107CrossRef
25.
Zurück zum Zitat Li XS, Fan HX, Fang H, Song YL, Zhou CW (2015) Value of R2* obtained from T2*-weighted imaging in predicting the prognosis of advanced cervical squamous carcinoma treated with concurrent chemoradiotherapy. J Magn Reson Imaging 42:681–688CrossRef Li XS, Fan HX, Fang H, Song YL, Zhou CW (2015) Value of R2* obtained from T2*-weighted imaging in predicting the prognosis of advanced cervical squamous carcinoma treated with concurrent chemoradiotherapy. J Magn Reson Imaging 42:681–688CrossRef
26.
Zurück zum Zitat Sturdza A, Potter R, Fokdal LU et al (2016) Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiother Oncol 120:428–433CrossRef Sturdza A, Potter R, Fokdal LU et al (2016) Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiother Oncol 120:428–433CrossRef
27.
Zurück zum Zitat Moore KN, Java JJ, Slaughter KN et al (2016) Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis. Gynecol Oncol 143:294–301CrossRef Moore KN, Java JJ, Slaughter KN et al (2016) Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis. Gynecol Oncol 143:294–301CrossRef
28.
Zurück zum Zitat Hirakawa M, Nagai Y, Inamine M et al (2008) Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy. Gynecol Oncol 108:126–129CrossRef Hirakawa M, Nagai Y, Inamine M et al (2008) Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy. Gynecol Oncol 108:126–129CrossRef
Metadaten
Titel
Value of blood oxygenation level-dependent MRI for predicting clinical outcomes in uterine cervical cancer treated with concurrent chemoradiotherapy
verfasst von
Jiyeong Lee
Chan Kyo Kim
Kyo-won Gu
Won Park
Publikationsdatum
23.04.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 11/2019
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-019-06198-5

Weitere Artikel der Ausgabe 11/2019

European Radiology 11/2019 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.